Egerton Capital (UK) LLP — CARPENTER TECHNOLOGY CORP CRS: Quarterly 13F Position History
Egerton Capital (UK) LLP has reported CARPENTER TECHNOLOGY CORP (CRS) on 5 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2025. As of Q1 2026, the position is sized at 1,330,920 shares ($524.6M market value, 5.82% of the equity book). Quarter-over-quarter share count change: 222,092 (-14.3%) .
- 1,330,920Shares Held (Latest Filing)
- $524.6MReported Market Value (Latest Filing)
- 5.82%Portfolio Weight (% of 13F Equity Book)
- 222,092Quarter-over-Quarter Share Change
- +$35.6MQuarter-over-Quarter Value Change
- 1,909,067Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,330,920 | 222,092 | -14.3% | $524.6M | 5.82% | $394.15 |
| Q4 2025 | 1,553,012 | +178,679 | +13.0% | $489.0M | 5.31% | $314.84 |
| Q3 2025 | 1,374,333 | 534,734 | -28.0% | $337.5M | 3.56% | $245.54 |
| Q2 2025 | 1,909,067 | +89,182 | +4.9% | $527.6M | 5.41% | $276.38 |
| Q1 2025 | 1,819,885 | — | — | $329.7M | 3.80% | $181.18 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Egerton Capital (UK) LLP first disclose a CRS position in 13F-HR filings?
Egerton Capital (UK) LLP first reported CARPENTER TECHNOLOGY CORP (CRS) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was Egerton Capital (UK) LLP's most recent quarter-over-quarter share-count change in CRS?
Between Q4 2025 and Q1 2026, Egerton Capital (UK) LLP reduced its CRS position by 222,092 shares (-14.3%), leaving 1,330,920 shares at a market value of $524.6M.
Does the implied price-per-share represent Egerton Capital (UK) LLP's cost basis in CRS?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.